The newly approved Prodisc C Vivo, Prodisc C Nova and Prodisc C SK are all designed for cervical disc replacements, according to a July 13 company news release. They received the FDA’s pre-market application approval for single-level applications.
Prodisc C Vivo and Prodisc C Nova have been used outside the U.S. since 2009. Prodisc C Vivo is the most-used total disc replacement device outside the U.S.
The new approvals bring the devicemaker to four total cervical disc replacement devices with PMA approval.
